What is Ascension-Q?
Based in Cheshire, United Kingdom, Ascension-Q operates as a sophisticated medtech enterprise and clinical trial management services provider. By streamlining the complexities inherent in pharmaceutical research and development, the company occupies a critical niche in the healthcare innovation ecosystem. Its operational model focuses on enhancing the efficiency of clinical trials, thereby accelerating the path from laboratory discovery to patient-ready medical solutions. As a key player in the UK life sciences sector, Ascension-Q leverages its proprietary methodologies to support global research initiatives, ensuring that data integrity and regulatory compliance remain at the forefront of its service delivery. The company's market position is bolstered by its ability to navigate the rigorous demands of modern clinical research, making it an essential partner for organizations seeking to optimize their development pipelines.
How much funding has Ascension-Q raised?
Ascension-Q has raised a total of $300K across 1 funding round:
Other Financing Round
$300K
Other Financing Round (2023): $300K with participation from Jenson Funding Partners
Key Investors in Ascension-Q
Jenson Funding Partners
Jenson Ventures specializes in SEIS and EIS investments, focusing on innovative founders and early-stage businesses. They employ a disciplined and inclusive investment strategy that aims to deliver sustainable value while supporting entrepreneurs who are committed to making a positive impact.
What's next for Ascension-Q?
With this recent capital injection, Ascension-Q is well-positioned to scale its operations and expand its footprint in the international clinical research market. The strategic allocation of these funds will likely prioritize the enhancement of its digital trial management platforms and the expansion of its expert workforce. As the company transitions through this late-stage growth phase, the focus will shift toward achieving greater operational leverage and securing long-term partnerships with global pharmaceutical entities. By reinforcing its technological infrastructure, Ascension-Q aims to solidify its reputation as a leader in clinical trial optimization, ultimately driving sustainable value for its stakeholders and contributing to the advancement of global healthcare standards.
See full Ascension-Q company page
